Investor Relations

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors
SAN DIEGO , Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced the appointment of Faheem Hasnain as Chairman of the Board of Directors,
View HTML
Toggle Summary Vital Therapies Announces Recent and Upcoming Scientific Presentations and Participation in Upcoming Investor Conference
SAN DIEGO , Sept. 11, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today provides an update on recent and upcoming scientific presentations.
View HTML
Toggle Summary Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
SAN DIEGO , Oct. 18, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its third quarter 2017 financial results after the market closes on Wednesday,
View HTML
Toggle Summary Vital Therapies Announces Third Quarter 2017 Financial Results
- 118 of Targeted 150 Subjects Enrolled in VTL-308 as of October 24th SAN DIEGO , Oct. 25, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results
View HTML
Toggle Summary Vital Therapies to Webcast Presentation at Upcoming Investor Conference
SAN DIEGO , Nov. 08, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced that the company will participate in the Stifel 2017 Healthcare Conference in
View HTML